| 产品名称 | Peptides EP14315_1 | HPV 16/18 E6 31-38 (HLA-B*40:02) |
|---|---|
| 目录号 | EP14315_1 |
| 别名 | HPV 16/18 E6 31-38 (HLA-B*40:02) |
| 外观 | 见COA |
| 分子量 | N/A |
| CAS | N/A |
| 溶解度 | |
| 存储条件 | 见COA |
| 保存时间 | 见COA |
| 备注1 | |
| 备注2 |
| 目录号 | 规格 | 价格 | 库存状态 | |
| EP14315_1 | 1 mg; 5 mg | 咨询 | 咨询 |
Peptides EP14315_1 | HPV 16/18 E6 31-38 (HLA-B*40:02)
品名:HPV 16/18 E6 31-38 (HLA-B*40:02)
货号:EP14315_1
规格:1 mg; 5 mg
品牌:Peptides.de
产品描述
HDIILECV is a short linear epitope (ID: 110624) mapped to the E6 proteins of Human papillomavirus type 16 and type 18, corresponding to amino acids 31 through 38 of the viral oncoprotein. The E6 sequences referenced are from UniProt entries P03126 (HPV-16) and P06463 (HPV-18), representing the species groups Alphapapillomavirus 9 and Alphapapillomavirus 7, respectively. E6 facilitates oncogenesis by destabilizing tumor suppressor proteins enabling infected cells to evade normal growth control mechanisms. Due to its conserved sequence and immunological relevance, the HDIILECV epitope has been analyzed in studies exploring HPV-specific immune responses, particularly in the context of vaccine development and T cell-mediated recognition of infected or transformed cells.
| Protein | Protein E6 |
| Species | HPV 16, HPV 18 |
| Application | Flow Cytometry |
| Indication | Infectious disease, Cancer |